Low-sodium versus usual-salt diet after heart failure hospitalization
Official title: Evaluating Effect of Low-Sodium and Regular Diets on Heart Failure Outcomes
Run by Rutgers, The State University of New Jersey · NCT07560592 · Data updated 2026-11-12
This will test whether a low-sodium (cardiac) diet lowers 30-day hospital readmissions for adults recently hospitalized with heart failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | November 10, 2027 |
| Study ends | November 2028 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT07560592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged over 18 who are hospitalized for heart failure and can be enrolled within 24 hours of admission are ideal candidates, provided they do not meet exclusion criteria.
✕Probably not a fit
Patients with uncontrolled hypertension on admission, end-stage renal disease requiring dialysis, or cardiogenic shock are excluded and would not receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults admitted with heart failure within 24 hours are assigned to either a low-sodium cardiac diet or a normal salt diet and followed for 30 days to record rehospitalizations. The trial excludes patients with markedly elevated blood pressure on admission, those on dialysis, and those in cardiogenic shock. Intake and clinical outcomes will be tracked to compare 30-day readmission rates between the two diet groups. Results aim to clarify whether sodium restriction after discharge affects short-term outcomes.
Why it matters
Potential benefit: If successful, results could reduce 30-day readmissions and help shape clear dietary guidance for patients after heart failure hospitalization.
How similar studies have gone: Previous research on sodium restriction in heart failure has shown mixed results, so the question remains unsettled and further data are needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Above 18 years of age * Hospitalization due to Heart Failure admitted within 24 hours Exclusion Criteria: * Concomitant hypertension (blood pressure \>150/90 mmHg on admission) * End stage renal disease (on hemodialysis or peritoneal dialysis * Cardiogenic shock
Where it's running
-
Robert Wood Johnson Barnabas Hospital - New Brunswick
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Maya Guglin, MD — Rutgers University
- Study coordinator: Maya Guglin, MD
- Email: maya.guglin@rutgers.edu
- Phone: 8483915776
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.